Literature DB >> 4608707

A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. A clinical and experimental-psychological study.

Z Cesarec, G Eberhard, L Nordgren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4608707     DOI: 10.1111/j.1600-0447.1974.tb08044.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


× No keyword cloud information.
  5 in total

1.  The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.

Authors:  J Gerlach; K Lühdorf
Journal:  Psychopharmacologia       Date:  1975-10-14

Review 2.  Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Authors:  Marc Krause; Yikang Zhu; Maximilian Huhn; Johannes Schneider-Thoma; Irene Bighelli; Adriani Nikolakopoulou; Stefan Leucht
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-01-24       Impact factor: 5.270

3.  Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.

Authors:  A Wolkin; B Angrist; A Wolf; J Brodie; B Wolkin; J Jaeger; R Cancro; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.

Authors:  R M Pinder; R N Brogden; R Swayer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  Study on clinical characteristics and related factors of schizophrenic patients with intestinal obstruction.

Authors:  Mingchao Li; Ping Guo; Jihua Zeng; Chi Li; Qiuming Ji; Yunqing Zhao; Haiying Chen; Ying Wang; Yunjiao Hu; Lianzhong Liu
Journal:  BMC Gastroenterol       Date:  2022-01-06       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.